Spotify Q2 2026 Earnings
Rev EU4.78B (est EU4.79B) - Gross Margin 33.4% (est 33.1%) - Monthly Active Users 777M (est 778.18M) - Total Premium Subscribers 300M (est 299.16M) - Sees Q3 Rev EU5B (est EU4.93B) - Sees Q3 Gross Margin 32.9% (est 32.9%) - Sees Q3 Total Premium Subscribers 305M (est 305.3M) - Sees Q3 MAU 788M (est 793.52M)
Story updates
10:24:48 AM UTC
SquawkNews
Spotify Q2 2026 Earnings
10:40:43 AM UTC
SquawkNews
Adj Loss/SHR 13C (Est Loss/SHR 23C) - Sales $16.61B (Est $16.35B) - Animal Health Sales $1.78B (Est $1.75B) - Gardasil Rev. $1.17B (Est $1.12B) - Keytruda Rev. $8.37B (Est $8.04B) - YR Adj EPS View Incl $9B Charges Tied To Cidara Deal - YR Adj EPS View Incl $5.7B Charges For Terns Deal - FY Adj EPS $2.66 To $2.76, Saw $5.04 To $5.16 - Sees FY Sales $66.3B To $67.3B, Saw $65.8B To $67B - Sees FY Adj Gross Margin About 81%, Saw About 82%
10:50:44 AM UTC
SquawkNews
Merck & Co Q2 2026 Earnings
10:52:37 AM UTC
SquawkNews
Adj Net Income (Excluding Notable Items) $2.11 - Total Rev $11.15B, +64% Y/Y - AUM $1.05T, +2.1% Q/Q - Fee-Related Earnings Margin 58.5% (est 58.1%) - Fee-Generating AUM $858B, +34% Y/Y - Fee-Related Earnings $785M) (est $771.6M)
11:02:37 AM UTC
SquawkNews
Apollo Global Q2 2026 Earnings
Adj Loss/SHR 13C (Est Loss/SHR 23C) - Sales $16.61B (Est $16.35B) - Animal Health Sales $1.78B (Est $1.75B) - Gardasil Rev. $1.17B (Est $1.12B) - Keytruda Rev. $8.37B (Est $8.04B) - YR Adj EPS View Incl $9B Charges Tied To Cidara Deal - YR Adj EPS View Incl $5.7B Charges For Terns Deal - FY Adj EPS $2.66 To $2.76, Saw $5.04 To $5.16 - Sees FY Sales $66.3B To $67.3B, Saw $65.8B To $67B - Sees FY Adj Gross Margin About 81%, Saw About 82%